Rituximab in Progressive IgA Nephropathy

Share this article:
Rituximab in Progressive IgA Nephropathy

Sponsor and Collaborators
Mayo Clinic
Georgia Health Sciences University
Ohio State University
Stanford University
University of North Carolina, Chapel Hill
Vanderbilt University
Columbia University

Contact
Fernando C Fervenza, M.D.
507-266-7961
fervenza.fernando@mayo.edu

Shirley Jennison
507-255-0231
jennison.shirley@mayo.edu

Principal Investigator
Fernando C. Fervenza, M.D., Mayo Clinic

ClinicalTrials.gov Identifier
NCT00498368
Share this article:
You must be a registered member of RUN to post a comment.
close

Next Article in Lupus Nephritis Clinical Trials

Sign Up for Free e-newsletters

More in Lupus Nephritis Clinical Trials

Low-dose VS High-dose IV Cyclophosphamide for Proliferative LN in Children (Low/highIVCY)

A look at the following clinical trial: Low-dose VS High-dose IV Cyclophosphamide for Proliferative LN in Children (Low/highIVCY).

Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL ...

A look at the following clinical trial: Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID).